An underground market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.
Experimental Drug Gaining Popularity Online
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these profiles privately for supplier links, while also receiving promotional offers.
Thriving Commerce on Social Networks
Separately, a robust market exists on Telegram, where communities with numerous of members share “before and after” images, administration instructions and assertions of next-day UK delivery. Sellers promote the drug there before redirecting customers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.
Healthcare Professionals Express Worries
However, physicians and chemists have cautions that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in users injecting products of uncertain source.
Some professionals stated the demand for the experimental drug could be connected to the rising price of approved slimming treatments such as Mounjaro.
Legal Position and Implementation
Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach pharmaceutical, marketing, and customer laws, risking penalties, prosecution or imprisonment.
Service Response and Material Elimination
According to the social media company, the service has removed problematic content and prohibited related hashtags and search suggestions. The company said it was committed to keeping the platform secure and investing in enhancing compliance measures.
Online Marketplace Operations
Research also discovered communities with up to nine thousand participants marketing the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of users, populated with images of slimming results, glowing reviews and detailed instructions for preparing or injecting at residence.
After moments of entering one community, a seller posted contact information, where the majority of purchases take place. The vendor provided an guidebook and promised delivery within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about body mass, medical conditions or past usage.
Product Information and Costs
Within these groups, posts show black plastic packages with postal service stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at home with purified liquid, or pre-filled pens usually sold at 160 pounds for 20 milligrams. When asked how long a pen should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.
Service Moderation and Security Measures
A spokesperson for Telegram stated it regularly moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are administering materials they can’t verify. Even if the research behind this drug is sound, these digital versions may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service connected the surge in demand to current price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are turning to social media. But fake injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.
Her staff has previously seen patients injured by personal administration from unconfirmed sources. “We understand the disappointment, but buying from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be impure or improperly measured.”
Manufacturer Statement
A spokesperson from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may expose patients to potentially serious health risks”.
